ClinicalTrials.govpublic full text
Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
fatty liver, hepatitis, nonalcoholic steatohepatitis, enzyme inhibitors, lipase, obesity, insulin resistance, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801679
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.